Mah Kheirabadi

Company: Entrada Therapeutics Inc.

Job title: Director - Discovery Chemistry

Seminars:

The Endosomal Escape Vehicle Platform Safely & Effectively Delivers Oligonucleotide Therapeutics to Skeletal and Cardiac Muscle Tissue for the Potential Treatment of Duchenne Muscular Dystrophy 3:30 pm

Developing the Endosomal Escape Vehicle (EEV™) family of cyclic cell-penetrating peptides that were developed to overcome limitations of intracellular therapeutics Delivering antisense oligonucleotides using EEV-PMO constructs to skeletal and cardiac muscle in preclinical models of Duchenne muscular dystrophy (DMD) Discussing how healthy human volunteers were administered a single dose of ENTR601-44, a DMD exon 44…Read more

day: Conference Day Two